RETAIN Program for Work-related Injuries
(MN RETAIN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how the RETAIN program (Minnesota Retaining Employment and Talent After Injury/Illness Network) can assist individuals in staying at work or returning to work after an injury or illness. Participants will either work with a dedicated case manager and access career resources or receive a job services handout. The trial is open to Minnesota residents who have been unable to work for at least four weeks due to a work-related or personal injury or illness. It is particularly suitable for those recently out of work and in need of job-related support. As an unphased trial, this study provides a unique opportunity for participants to access valuable support and resources to aid their return to work.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that the RETAIN program is safe for workforce retention and reduction of workplace disability?
Research shows that the RETAIN Program helps workers stay at or return to work after an injury or illness. It emphasizes early intervention, assisting people in returning to work as soon as it is safe. Studies have shown that these strategies improve outcomes for workers, enabling them to continue their jobs or find new ones if necessary.
As the program focuses on support and guidance rather than medical treatment, reports of physical side effects or negative reactions, common in drug trials, are absent. Instead, the program provides resources and case managers to assist workers in their return to work. This indicates the program is well-tolerated, offering support rather than medical interventions.12345Why are researchers excited about this trial?
Researchers are excited about the RETAIN Program because it offers a personalized approach to helping individuals return to work after an injury. Unlike traditional methods that might only provide generic resources, this program assigns each participant a dedicated Return-to-Work Case Manager from Minnesota. This personalized support is supplemented with referrals to additional career and workforce development resources when needed, ensuring a comprehensive and tailored recovery pathway. This individualized attention could lead to more effective and faster reintegration into the workforce, which is why it holds promise compared to standard options.
What evidence suggests that the RETAIN Program is effective for improving workforce retention and reducing workplace disability?
Research has shown that the RETAIN Program helps workers return to their jobs or stay employed after an injury or illness. In this trial, participants in the Intervention Group will receive a dedicated Minnesota RETAIN Return-to-Work Case Manager and access to additional career and workforce development resources. Studies have found that the program's early support strategies can help keep people in their jobs and reduce future work-related disabilities. Early data suggests that people in the program use more services and have better job outcomes compared to those in the Control Group, who receive a handout with additional job-related services. Overall, the evidence supports the program's success in helping workers return to work sooner and remain employed.14567
Who Is on the Research Team?
Laura Breeher, MD, MPH
Principal Investigator
Mayo Clinic
Clayton Cowl, MD,MS
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
The Minnesota RETAIN Phase 2 trial is for Minnesota residents who have had or will have surgery affecting their work within the last 12 weeks or next 8 weeks. Participants must have worked in MN at least one day in the past 3 months, be over 18, and employed or active in the labor force. It's not for those with worker's comp having a QRC/DCM, involved in related litigation, unable to consent, employed by certain organizations with return-to-work programs, or on SSDI/SSI.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are assigned a dedicated Minnesota RETAIN Return-to-Work Case Manager and referred for additional career and workforce development resources as needed
Follow-up
Participants are monitored for workforce retention and reduction of workplace disability
Long-term Follow-up
Participants are monitored for long-term work disability reduction
What Are the Treatments Tested in This Trial?
Interventions
- RETAIN Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Minnesota Department of Employment and Economic Development
Collaborator
Minnesota Department of Health
Collaborator
Mathematica Policy Research
Collaborator
United States Department of Labor
Collaborator
Minnesota Department of Labor and Industry
Collaborator
United States Social Security Administration
Collaborator
Workforce Development, Inc.
Collaborator